phenylalanyl-phenylalanyl-arginyl-recombinant FVIIa

Known as: FFR-rVIIa 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
024619962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVES To assess the safety and efficacy of fractional flow reserve (FFR) guided paclitaxel-coated balloon (PCB) treatment… (More)
Is this relevant?
2015
2015
Fractional flow reserve (FFR) is an index for identifying functionally significant stenotic lesions. A FFR value of ≤0.75 is… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND The prognostic value of poststent fractional flow reserve (FFR) has not been clearly defined in patients with drug… (More)
Is this relevant?
2009
2009
The National Institute for Occupational Safety and Health (NIOSH) and European Norms (ENs) employ different test protocols for… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
OBJECTIVE To evaluate the safety and efficacy of active site inactivated recombinant factor VIIa (FFR-rFVIIa) in patients with… (More)
Is this relevant?
2006
2006
The initial recognition and binding of macromolecular substrates by factor VIIa (FVIIa) in complex with tissue factor has been… (More)
Is this relevant?
2005
2005
Tissue factor (TF) is believed to play an important role in coagulation, inflammation, angiogenesis and wound healing as well as… (More)
Is this relevant?
2002
2002
FFR-rFVIIa is an inactivated recombinant factor VIIa (rFVIIa) that inhibits the binding of factor VIIa to tissue factor (TF). It… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2001
2001
Active site-inhibited factor VIIa (FFR-rFVIIa) competes with factor VIIa (FVIIa) for binding to tissue factor (TF) and exerts an… (More)
Is this relevant?
1998
1998
OBJECTIVE To study whether locally administered recombinant inactivated human coagulation factor VIIa (FFR-rFVIIa) would reduce… (More)
Is this relevant?